JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 33 No. 3 355-358
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Latham, T. B.
Right arrow Articles by Reese, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Latham, T. B.
Right arrow Articles by Reese, L.

Effects of Dipyridamole Infusion on Human Renal Function Observed Using Technetium-99m-DTPA

Timothy B. Latham, Frank S. Prato, Gerald Wisenberg and Lionel Reese

Departments of Medicine and Nuclear Medicine & Magnetic Resonance, St. Joseph's Health Centre, Lawson Research Institute University of Western Ontario, London, Ontario, Canada

Correspondence: For reprints contact: Dr. Drank Prato, PhD, FCCPM, ABMP, Department of Nuclear Medicine & Magnetic Resonance, St. Joseph's Health Centre, 268 Grosvenor St., London, Ontario, Canada N6A 4V2.

ABSTRACT

Our observation that a prolonged dipyridamole infusion reduced or eliminated blood clearance of Gd-DTPA in dogs led us to investigate if dipyridamole, infused intravenously at rates comparable to those used in thallium myocardial perfusion tests, would alter renal filtration in humans. Renal filtration was assessed using a bolus injection of 10 mCi of 99mTc-DTPA in five males (19–63 yr old) with normal serum urea and creatinine. Twenty minutes following the bolus injection a 10-min intravenous infusion of either dipyndamole (0.14 mg/kg/min) or saline sham was given. Four to 10 min following the start of the dipyndamole infusion, a paradoxical rise in counts in the kidney region of interest was observed and persisted for 10 to 27 min. During this time, a 13% to 52% (mean±s.d., 40%±16%, p<0.007) reduction in the exponential slope defining the clearance of counts from the cardiac region of interest occurred (implying a reduction of glomerular filtration rate), mean heart rate increased 27±5 bpm, p<0.002 and mean diastolic pressure decreased 12.9±6.4 mmHg, p<0.028. This finding indicates that renal clearance of tracers such as thallium or contrast agents such as Gd-DTPA is reduced during dipyndamole infusion.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1992 by the Society of Nuclear Medicine.